4th Year MBBS
Neuroscience
Sleep Disorders, Insomnia and Sedative–Hypnotic Pharmacology
A rapid integration of sleep problems, behavioural management and the major pharmacological pathways used to reduce anxiety or promote sleep.
Structured according to the supplied AIM Concept Integration framework. :contentReference[oaicite:0]{index=0}
1. THE TOPIC IN ONE CONNECTED FLOW
Sleep complaints become easier to understand when they are approached in sequence: first identify the type of sleep problem, then recognize the mechanism maintaining it, and finally select behavioural or pharmacological treatment that matches that mechanism. Drug therapy is useful only when its benefits outweigh sedation, dependence and interaction risks.
Poor sleep, abnormal timing, excessive sleepiness or abnormal sleep behaviour
Insomnia, circadian disorder, hypersomnolence, breathing disorder, movement disorder or parasomnia
Behavioural arousal, circadian misalignment, sleep deprivation or need for CNS inhibition
Sleep hygiene, CBT-I, safety measures or timed light and sleep scheduling
GABA-A modulation, 5-HT1A modulation or melatonin-receptor activation
Sleep or anxiolytic benefit versus next-day sedation, tolerance, dependence and toxicity
Benzodiazepines → enhance GABA-A activity → anxiolysis, sedation, hypnosis, anticonvulsant and muscle-relaxant effects.
|
Barbiturates → stronger GABA-mediated CNS depression → useful in selected indications but greater overdose risk.
|
Buspirone → 5-HT1A partial agonism → gradual anxiolysis with little sedation.
|
Ramelteon → MT1/MT2 activation → facilitates sleep onset.
2. KEY CLINICAL CONNECTIONS
Poor sleep → worry about sleep → increased bedtime arousal → further difficulty sleeping.
Connection: CBT-I and sleep-hygiene measures act on the maintaining behaviour and thoughts rather than merely producing temporary sedation.
GABA-A facilitation → reduced neuronal excitability → anxiolysis and hypnosis.
Connection: The same CNS inhibition can also produce drowsiness, ataxia and psychomotor impairment; repeated use may lead to tolerance and dependence.
Incomplete arousal from deep non-REM sleep → sleepwalking → impaired awareness and poor recall.
Circadian misalignment → sleep occurs at the wrong biological time → structured timing and appropriately timed light help realign sleep.
3. AIM HIGH-YIELD INTEGRATION REVIEW
Benzodiazepines increase the frequency of GABA-A chloride-channel opening, whereas barbiturates increase the duration of channel opening. This mechanistic distinction helps explain the greater CNS-depressant toxicity of barbiturates.